Unknown Animal/Cell Subjects in MS Research on HLA-DRB1 Polymorphisms
This study indicates that the peptide EBNA1400-413 does not mimic the interaction mode of MBP85-99 in the binding groove, and in higher-risk alleles DRB1*15:01 and DRB1*15:03, the complexes show lower variability, occupying favorable energy states. Machine learning models discern distinct patterns between these autoantigens.
- Tags
- #MSResearch
- Most relevant to
- —
Why it matters
These findings aid in understanding the role of HLA-DRB1 polymorphisms in MS risk by revealing how they may affect peptide presentation and conformational stability.
What this does not prove
The study lacks specific data on human multiple sclerosis and does not directly link findings to clinical outcomes, limiting broader applicability.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-09-17
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Primary evidenceHLA-DRB1 Polymorphisms Modulate the Dynamic Compatibility between the Presentation of EBNA1400-413 and MBP85-99. ↗DOI: 10.1021/acsomega.6c06047
Supporting passages (4)
study phaseTo this end, molecular dynamics simulations were integrated with machine learning models trained using inter-residue distances at the pHLA interface as input attributes, allowing evaluation of how different peptides modulate the conformational stability of the complexes and identification of which interface regions contribute to distinguishing alleles associated with higher and lower risk.
publication datePublication date: 2026-09-17
findingsThus, this study proposes a mechanism of functional mimicry dependent on pHLA interface dynamics, in which HLA-DRB1 polymorphisms modulate the presentation of self and viral peptides.
limitationsTitle: HLA-DRB1 Polymorphisms Modulate the Dynamic Compatibility between the Presentation of EBNA1400-413 and MBP85-99.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.